Infliximab and primary Sjogren's syndrome: comment on the article by Mariette et al

Arthritis Rheum. 2004 Dec;50(12):4077; author reply 4077-8. doi: 10.1002/art.20803.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Fibromyalgia / complications
  • Fibromyalgia / diagnosis*
  • Fibromyalgia / physiopathology
  • Humans
  • Infliximab
  • Randomized Controlled Trials as Topic*
  • Sjogren's Syndrome / complications
  • Sjogren's Syndrome / drug therapy*
  • Sjogren's Syndrome / physiopathology
  • Treatment Failure

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab